State Street’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $42.8M | Buy |
1,091,106
+38,244
| +4% | +$1.06M | ﹤0.01% | 1825 |
|
|
2025
Q4 | $16.2M | Buy |
1,052,862
+87,725
| +9% | +$1.75M | ﹤0.01% | 2374 |
|
|
2025
Q3 | $19.8M | Buy |
965,137
+148,895
| +18% | +$3M | ﹤0.01% | 2255 |
|
|
2025
Q2 | $16.4M | Buy |
816,242
+35,340
| +5% | +$669K | ﹤0.01% | 2299 |
|
|
2025
Q1 | $15.4M | Sell |
780,902
-20,930
| -3% | -$450K | ﹤0.01% | 2276 |
|
|
2024
Q4 | $18M | Buy |
801,832
+55,888
| +7% | +$1.45M | ﹤0.01% | 2280 |
|
|
2024
Q3 | $19.1M | Buy |
745,944
+21,018
| +3% | +$487K | ﹤0.01% | 2236 |
|
|
2024
Q2 | $16.9M | Buy |
724,926
+233,078
| +47% | +$4.91M | ﹤0.01% | 2251 |
|
|
2024
Q1 | $8.65M | Buy |
491,848
+7,333
| +2% | +$113K | ﹤0.01% | 2668 |
|
|
2023
Q4 | $6.71M | Buy |
484,515
+13,663
| +3% | +$167K | ﹤0.01% | 2798 |
|
|
2023
Q3 | $6.43M | Buy |
470,852
+4,601
| +1% | +$77.5K | ﹤0.01% | 2811 |
|
|
2023
Q2 | $9.52M | Buy |
466,251
+456,827
| +4,847% | +$9.23M | ﹤0.01% | 2673 |
|
|
2023
Q1 | $206K | Sell |
9,424
-1
| -0% | -$20 | ﹤0.01% | 4068 |
|
|
2022
Q4 | $154K | Buy |
9,425
+4,125
| +78% | +$65.9K | ﹤0.01% | 4216 |
|
|
2022
Q3 | $48K | Hold |
5,300
| – | – | ﹤0.01% | 4665 |
|
|
2022
Q2 | $26K | Hold |
5,300
| – | – | ﹤0.01% | 4838 |
|
|
2022
Q1 | $40K | Hold |
5,300
| – | – | ﹤0.01% | 4833 |
|
|
2021
Q4 | $48K | Hold |
5,300
| – | – | ﹤0.01% | 4707 |
|
|
2021
Q3 | $86K | Hold |
5,300
| – | – | ﹤0.01% | 4577 |
|
|
2021
Q2 | $167K | Sell |
5,300
-22,346
| -81% | -$693K | ﹤0.01% | 4253 |
|
|
2021
Q1 | $933K | Buy |
27,646
+1,320
| +5% | +$67.1K | ﹤0.01% | 3636 |
|
|
2020
Q4 | $2.32M | Buy |
26,326
+10,323
| +65% | +$866K | ﹤0.01% | 3304 |
|
|
2020
Q3 | $1.3M | Buy |
16,003
+1,927
| +14% | +$174K | ﹤0.01% | 3358 |
|
|
2020
Q2 | $1.56M | Buy |
+14,076
| New | +$1.58M | ﹤0.01% | 3280 |
|
Other funds holding ELVN
O
PCH
CC
VPC
BG
VCM
FFM
